2025-05-30 - Analysis Report
Okay, here's an analysis of Schrodinger Inc (SDGR) based on the provided data, presented in English with an emphasis on key numerical takeaways and concise summaries.

## Schrodinger Inc (SDGR) Analysis - [Current Date]

**Ticker:** SDGR
**Company:** Schrodinger Inc
**Description:** Schrodinger Inc. is a company that develops software for drug discovery and materials science.

### 1. Performance vs. S&P 500 (VOO)

*   **SDGR Cumulative Return:** -47.93%
*   **VOO Cumulative Return:** 37.02%
*   **Absolute Divergence:** -84.9%
*   **Relative Divergence:** 6.8 (on a scale where the historical range from min to max is 100)

**Analysis:** SDGR has significantly underperformed the S&P 500 (VOO). The absolute divergence is substantial.  The relative divergence of 6.8 indicates that the current divergence is near the lowest end of its historical range, suggesting significant underperformance relative to its past performance versus the S&P 500.

| Year       | CAGR   | MDD    | Alpha  | Beta   | Cap(B) |
|------------|--------|--------|--------|--------|--------|
| 2020-2022  | -74.0% | 68.9%  | -92.0% | -0.0   | 1.4    |
| 2021-2023  | -65.0% | 68.9%  | -81.0% | -0.0   | 2.6    |
| 2022-2024  | 8.0%   | 72.4%  | -8.0%  | -0.0   | 1.4    |
| 2023-2025  | 5.0%   | 74.3%  | -24.0% | -0.0   | 1.6    |

**Analysis:** The table shows a history of negative CAGR and significant Maximum Drawdown (MDD), with a negative alpha. The beta value is consistently -0.0 indicating SDGR's returns are not positively correlated with the market.  More recent periods (2022-2024 and 2023-2025) show positive CAGR, but high MDD and negative Alpha remain concerns.

### 2. Recent Price Action

*   **Current Price:** \$21.44
*   **Previous Close:** \$21.52
*   **Change:** -0.37%
*   **5-Day Moving Average:** \$21.42
*   **20-Day Moving Average:** \$23.13
*   **60-Day Moving Average:** \$22.66

**Analysis:** The stock is trading slightly below its previous close. The 5-day moving average is below the 20-day and 60-day moving averages, suggesting a short-term downward trend.

### 3. Market Risk Indicator & Other Metrics

*   **MRI:** 0.37 (Low Risk)
*   **RSI:** 28.97 (Oversold)
*   **PPO:** -1.29
*   **Hybrid Signal:** cash_69%_Sell 0.7% of holdings (3 shares - Caution - MRI:0.35)
*   **Delta Previous Relative Divergence:** -1.0 (Negative, indicating recent short-term decline)
*   **Expected Return (vs S&P 500):** -769.0% (Long-term, negative)

**Analysis:** The MRI indicates low market risk. The RSI is in oversold territory, potentially suggesting a possible bounce. The PPO is negative. The hybrid signal suggests a cautious stance, recommending selling a small portion of holdings and holding a significant cash position. The recent negative change in relative divergence confirms the short-term downward momentum. The extremely negative expected return suggests significant underperformance compared to the S&P 500 over the long term.  The small negative change (-0.37%) from the previous close doesn't suggest a significant volatility event on its own.

### 4. Recent News & Significant Events

*   **2025-05-30:** Major business developments, regulatory changes, or market events.
*   **2025-05-26:** Analyst discussions of performance, industry trends, and economic factors.
*   **2025-05-27:** Notable stock volatility influenced by recent news, earnings, or executive actions.
*   **2025-05-29:** Market expert advice to monitor recent news and company announcements, highlighting risks and opportunities.

**Analysis:** Recent news suggests volatility, potential challenges, and the need for investors to closely monitor company developments and market sentiment.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출     |
|------------|--------|----------|
| 2025-05-07 | -0.82  | 0.06 B$  |
| 2024-11-12 | -0.52  | 0.04 B$  |
| 2024-07-31 | -0.74  | 0.05 B$  |
| 2024-05-01 | -0.76  | 0.04 B$  |
| 2025-05-07 | -0.76  | 0.04 B$  |

**Analysis:** The company consistently reports negative EPS. Revenue has fluctuated, but has generally remained low. This trend is a significant concern.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-03-31 | \$0.06B | 52.26%        |
| 2024-12-31 | \$0.09B | 72.61%        |
| 2024-09-30 | \$0.04B | 50.24%        |
| 2024-06-30 | \$0.05B | 66.20%        |
| 2024-03-31 | \$0.04B | 51.61%        |

**Capital and Profitability:**

| Quarter    | Equity  | ROE      |
|------------|---------|----------|
| 2025-03-31 | \$0.37B | -16.01%  |
| 2024-12-31 | \$0.42B | -9.54%   |
| 2024-09-30 | \$0.45B | -8.49%   |
| 2024-06-30 | \$0.47B | -11.40%  |
| 2024-03-31 | \$0.51B | -10.65%  |

**Analysis:**  While the profit margins are high, the revenue is still relatively low. Equity is decreasing over the period, and the Return on Equity (ROE) is consistently negative, reflecting poor profitability and inefficient use of equity.

### 7. Overall Summary

Schrodinger Inc. (SDGR) is currently facing significant challenges.  The stock has significantly underperformed the S&P 500, and its historical performance shows negative alpha and high maximum drawdowns. While recent news hints at potential opportunities, the consistent negative EPS, low revenue, decreasing equity, and negative ROE raise serious concerns. The extremely negative expected return versus the S&P 500 underscores the risks. While the RSI is oversold and the MRI indicates low risk, the overall picture suggests a high-risk investment. The Hybrid Signal recommending selling a small portion of holdings is a prudent approach given the current data. Investors should exercise extreme caution and carefully consider the company's future prospects and financial health before making any investment decisions.
